Report Detail

Medical Devices & Consumables Global Powder-based, Needle-free Injection System Market Report 2018-2029

  • RnM3875587
  • |
  • 22 August, 2023
  • |
  • Global
  • |
  • 136 Pages
  • |
  • HJResearch
  • |
  • Medical Devices & Consumables

The Powder-based, Needle-free Injection System industry provides a revolutionary alternative to traditional needle injections. These systems deliver medication or vaccines through the use of compressed gas or mechanical force, propelling a fine stream of powdered medication into the skin without the need for needles. The Powder-based, Needle-free Injection System offers numerous advantages, including reduced pain and anxiety, improved safety, and increased convenience.

Definition and Use:
Powder-based, Needle-free Injection Systems employ powdered medication or vaccines that are propelled into the skin using various technologies. The powder is finely dispersed and injected at high velocity, penetrating the skin's surface and delivering the medication directly into the underlying tissue. These systems find applications in diverse medical procedures such as cardiovascular surgeries, general surgeries, gynecological surgeries, orthopedic surgeries, ophthalmic surgeries, and others.

Industry Status:
The global Powder-based, Needle-free Injection System market is projected to reach a market size of US$134 million in 2022, with a compound annual growth rate of 16.3%. Several factors contribute to the current state of the industry.

Advantages over Traditional Injections: Powder-based, Needle-free Injection Systems offer numerous advantages compared to traditional needle injections. These include reduced pain, improved patient comfort, elimination of needle phobia, minimized risk of needlestick injuries, and decreased cross-contamination risks.

Growing Demand for Minimally Invasive Procedures: Minimally invasive procedures have gained popularity due to their benefits, such as shorter recovery times, reduced scarring, and lower healthcare costs. Powder-based, Needle-free Injection Systems align with this trend by eliminating the use of needles, offering a less invasive and more patient-friendly method of drug delivery.

Technological Advancements: Ongoing advancements in Powder-based, Needle-free Injection System technology have resulted in more precise and efficient systems. Improved delivery mechanisms, enhanced dosage accuracy, and increased ease of use contribute to the industry's growth and acceptance.

Prospects and Opportunities:
The Powder-based, Needle-free Injection System industry demonstrates promising prospects for future expansion and development.

Increasing Adoption in Healthcare Facilities: The advantages offered by Powder-based, Needle-free Injection Systems are driving their adoption in diverse healthcare settings. Hospitals, clinics, and other medical facilities are recognizing the benefits of these systems, leading to increased usage across various medical procedures.

Expansion into New Application Areas: While the current major applications of Powder-based, Needle-free Injection Systems lie in surgeries, there is potential for expansion into new application areas. Research and development efforts are exploring the use of these systems in areas such as diabetes management, vaccination programs, and self-administration of medications.

Technological Innovations: Continued research and development endeavors aim to further enhance the performance and capabilities of Powder-based, Needle-free Injection Systems. Advancements include improved dose accuracy, reduced variability, integration with digital platforms for tracking and monitoring injections, and the development of personalized medicine delivery systems.

Market Penetration in Emerging Economies: As healthcare infrastructure continues to improve in emerging economies, the demand for innovative medical technologies also increases. The Powder-based, Needle-free Injection System industry can tap into these markets by offering cost-effective solutions and collaborating with local healthcare providers.

Conclusion:
The Powder-based, Needle-free Injection System industry is poised for significant growth, driven by its advantages over traditional needle injections, increasing demand for minimally invasive procedures, and technological advancements. With a projected market size of US$134 million in 2022 and a compound annual growth rate of 16.3%, the industry offers substantial opportunities for expansion.

Major global manufacturers, including ANTARES PHARMA, INC., ENDO INTERNATIONAL PLC, PHARMAJET, INC., INOVIO PHARMACEUTICALS, INC., MEDICAL INTERNATIONAL TECHNOLOGY, INC., NATIONAL MEDICAL PRODUCTS, INC., VALERITAS, INC., EUROPEAN PHARMA GROUP, and PENJECT CORPORATION, play a significant role in driving innovation, research, and market growth within the Powder-based, Needle-free Injection System industry.

By capitalizing on the advantages of Powder-based, Needle-free Injection Systems, exploring new applications, focusing on technological advancements, and targeting emerging markets, the industry can continue to thrive, improve patient experiences, and revolutionize drug delivery methods globally.

The SWOT analysis of the Powder-based, Needle-free Injection System industry is as follows:

Strengths:
Innovative and Advanced Technology: Powder-based, Needle-free Injection Systems offer a technologically advanced alternative to traditional needle injections, providing a range of benefits such as reduced pain, improved patient comfort, and enhanced safety.
Growing Demand for Minimally Invasive Procedures: The industry capitalizes on the increasing demand for minimally invasive surgeries and procedures, aligning with the preferences of both healthcare providers and patients.
Advantages over Traditional Injections: Powder-based, Needle-free Injection Systems eliminate the need for needles, reducing the risk of needlestick injuries, cross-contamination, and needle phobia. This advantage enhances the overall safety and convenience of drug delivery.
Expansion into Various Medical Specialties: The versatility of Powder-based, Needle-free Injection Systems allows for their use in a wide range of medical specialties, including cardiovascular surgeries, general surgeries, gynecological surgeries, orthopedic surgeries, ophthalmic surgeries, and more.

Weaknesses:
Initial High Costs: The initial cost of adopting Powder-based, Needle-free Injection Systems can be higher compared to traditional injection methods. This may limit the adoption rate among healthcare facilities, particularly those with limited budgets.
Limited Awareness and Acceptance: Despite the advantages they offer, Powder-based, Needle-free Injection Systems may face challenges in terms of creating awareness and gaining acceptance among healthcare professionals and patients who are accustomed to traditional injection methods.

Opportunities:
Increasing Market Penetration in Emerging Economies: As emerging economies continue to improve their healthcare infrastructure, there is an opportunity for the Powder-based, Needle-free Injection System industry to expand its market presence by offering affordable options and collaborating with local healthcare providers.
Research and Development: Ongoing research and development efforts can lead to further advancements in Powder-based, Needle-free Injection System technology, improving accuracy, efficacy, and usability. This presents opportunities for manufacturers to introduce new and improved products to the market.

Threats:
Stringent Regulatory Requirements: The Powder-based, Needle-free Injection System industry is subject to regulations and standards imposed by regulatory bodies. Compliance with these requirements can pose challenges for manufacturers, leading to potential delays in product development and market entry.
Competition from Traditional Injection Methods: Though Powder-based, Needle-free Injection Systems offer various advantages, traditional injection methods still dominate the market. The industry needs to compete with long-established practices and convince healthcare providers of the value and benefits of adopting these new technologies.
Potential Safety Concerns: While Powder-based, Needle-free Injection Systems are generally safe, there may be concerns related to device malfunctions, user errors, or adverse reactions to powdered medications. These safety issues could impact the industry's reputation and adoption rate if not addressed effectively.

Key players in global Powder-based, Needle-free Injection System market include:
ANTARES PHARMA, INC.
ENDO INTERNATIONAL PLC
PHARMAJET, INC.
INOVIO PHARMACEUTICALS, INC.
MEDICAL INTERNATIONAL TECHNOLOGY, INC.
MEDICAL INTERNATIONAL TECHNOLOGY, INC.
NATIONAL MEDICAL PRODUCTS, INC.
VALERITAS, INC.
EUROPEAN PHARMA GROUP
PENJECT CORPORATION

Market segmentation, by product types:
Jet
Spring
Laser
Vibration

Market segmentation, by applications:
Cardiovascular Surgeries
General Surgeries
Gynecological Surgeries
Orthopedic Surgeries
Ophthalmic Surgeries
Other


1 Industry Overview of Powder-based, Needle-free Injection System

  • 1.1 Research Scope
  • 1.2 Market Segmentation by Types of Powder-based, Needle-free Injection System
  • 1.3 Market Segmentation by End Users of Powder-based, Needle-free Injection System
  • 1.4 Market Dynamics Analysis of Powder-based, Needle-free Injection System
    • 1.4.1 Market Drivers
    • 1.4.2 Market Challenges
    • 1.4.3 Market Opportunities
    • 1.4.4 Porter’s Five Forces

2 Major Manufacturers Analysis of Powder-based, Needle-free Injection System Industry

  • 2.1 ANTARES PHARMA, INC.
    • 2.1.1 Company Overview
    • 2.1.2 Main Products and Specifications
    • 2.1.3 Powder-based, Needle-free Injection System Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.1.4 Contact Information
  • 2.2 ENDO INTERNATIONAL PLC
    • 2.2.1 Company Overview
    • 2.2.2 Main Products and Specifications
    • 2.2.3 Powder-based, Needle-free Injection System Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.2.4 Contact Information
  • 2.3 PHARMAJET, INC.
    • 2.3.1 Company Overview
    • 2.3.2 Main Products and Specifications
    • 2.3.3 Powder-based, Needle-free Injection System Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.3.4 Contact Information
  • 2.4 INOVIO PHARMACEUTICALS, INC.
    • 2.4.1 Company Overview
    • 2.4.2 Main Products and Specifications
    • 2.4.3 Powder-based, Needle-free Injection System Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.4.4 Contact Information
  • 2.5 MEDICAL INTERNATIONAL TECHNOLOGY, INC.
    • 2.5.1 Company Overview
    • 2.5.2 Main Products and Specifications
    • 2.5.3 Powder-based, Needle-free Injection System Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.5.4 Contact Information
  • 2.6 MEDICAL INTERNATIONAL TECHNOLOGY, INC.
    • 2.6.1 Company Overview
    • 2.6.2 Main Products and Specifications
    • 2.6.3 Powder-based, Needle-free Injection System Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.6.4 Contact Information
  • 2.7 NATIONAL MEDICAL PRODUCTS, INC.
    • 2.7.1 Company Overview
    • 2.7.2 Main Products and Specifications
    • 2.7.3 Powder-based, Needle-free Injection System Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.7.4 Contact Information
  • 2.8 VALERITAS, INC.
    • 2.8.1 Company Overview
    • 2.8.2 Main Products and Specifications
    • 2.8.3 Powder-based, Needle-free Injection System Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.8.4 Contact Information
  • 2.9 EUROPEAN PHARMA GROUP
    • 2.9.1 Company Overview
    • 2.9.2 Main Products and Specifications
    • 2.9.3 Powder-based, Needle-free Injection System Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.9.4 Contact Information
  • 2.10 PENJECT CORPORATION
    • 2.10.1 Company Overview
    • 2.10.2 Main Products and Specifications
    • 2.10.3 Powder-based, Needle-free Injection System Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.10.4 Contact Information

3 Global Powder-based, Needle-free Injection System Market Analysis by Regions, Manufacturers, Types and End Users

  • 3.1 Global Sales Volume and Revenue of Powder-based, Needle-free Injection System by Regions (2018-2023)
  • 3.2 Global Sales Volume and Revenue of Powder-based, Needle-free Injection System by Manufacturers (2018-2023)
  • 3.3 Global Sales Volume and Revenue of Powder-based, Needle-free Injection System by Types (2018-2023)
  • 3.4 Global Sales Volume and Revenue of Powder-based, Needle-free Injection System by End Users (2018-2023)
  • 3.5 Selling Price Analysis of Powder-based, Needle-free Injection System by Regions, Manufacturers, Types and End Users in (2018-2023)

4 Northern America Powder-based, Needle-free Injection System Market Analysis by Countries, Types and End Users

  • 4.1 Northern America Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 4.2 Northern America Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by Types (2018-2023)
  • 4.3 Northern America Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 4.4 United States Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 4.5 Canada Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)

5 Europe Powder-based, Needle-free Injection System Market Analysis by Countries, Types and End Users

  • 5.1 Europe Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 5.2 Europe Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by Types (2018-2023)
  • 5.3 Europe Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 5.4 Germany Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.5 France Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.6 UK Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.7 Italy Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.8 Russia Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.9 Spain Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.10 Netherlands Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)

6 Asia Pacific Powder-based, Needle-free Injection System Market Analysis by Countries, Types and End Users

  • 6.1 Asia Pacific Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 6.2 Asia Pacific Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by Types (2018-2023)
  • 6.3 Asia Pacific Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 6.4 China Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.5 Japan Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.6 Korea Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.7 India Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.8 Australia Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.9 Indonesia Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.10 Vietnam Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)

7 Latin America Powder-based, Needle-free Injection System Market Analysis by Countries, Types and End Users

  • 7.1 Latin America Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 7.2 Latin America Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by Types (2018-2023)
  • 7.3 Latin America Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 7.4 Brazil Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.5 Mexico Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.6 Argentina Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.7 Colombia Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)

8 Middle East & Africa Powder-based, Needle-free Injection System Market Analysis by Countries, Types and End Users

  • 8.1 Middle East & Africa Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 8.2 Middle East & Africa Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by Types (2018-2023)
  • 8.3 Middle East & Africa Powder-based, Needle-free Injection System Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 8.4 Turkey Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.5 Saudi Arabia Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.6 South Africa Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.7 Egypt Powder-based, Needle-free Injection System Sales Volume, Revenue, Import and Export Analysis (2018-2023)

9 Marketing Channel, Distributors and Traders Analysis

  • 9.1 Marketing Channel
    • 9.1.1 Direct Channel
    • 9.1.2 Indirect Channel
  • 9.2 Distributors and Traders

10 Global Powder-based, Needle-free Injection System Market Forecast by Regions, Countries, Manufacturers, Types and End Users

  • 10.1 Global Sales Volume and Revenue Forecast of Powder-based, Needle-free Injection System by Regions (2024-2029)
  • 10.2 Global Sales Volume and Revenue Forecast of Powder-based, Needle-free Injection System by Types (2024-2029)
  • 10.3 Global Sales Volume and Revenue Forecast of Powder-based, Needle-free Injection System by End Users (2024-2029)
  • 10.4 Global Revenue Forecast of Powder-based, Needle-free Injection System by Countries (2024-2029)
    • 10.4.1 United States Revenue Forecast (2024-2029)
    • 10.4.2 Canada Revenue Forecast (2024-2029)
    • 10.4.3 Germany Revenue Forecast (2024-2029)
    • 10.4.4 France Revenue Forecast (2024-2029)
    • 10.4.5 UK Revenue Forecast (2024-2029)
    • 10.4.6 Italy Revenue Forecast (2024-2029)
    • 10.4.7 Russia Revenue Forecast (2024-2029)
    • 10.4.8 Spain Revenue Forecast (2024-2029)
    • 10.4.9 Netherlands Revenue Forecast (2024-2029)
    • 10.4.10 China Revenue Forecast (2024-2029)
    • 10.4.11 Japan Revenue Forecast (2024-2029)
    • 10.4.12 Korea Revenue Forecast (2024-2029)
    • 10.4.13 India Revenue Forecast (2024-2029)
    • 10.4.14 Australia Revenue Forecast (2024-2029)
    • 10.4.15 Indonesia Revenue Forecast (2024-2029)
    • 10.4.16 Vietnam Revenue Forecast (2024-2029)
    • 10.4.17 Brazil Revenue Forecast (2024-2029)
    • 10.4.18 Mexico Revenue Forecast (2024-2029)
    • 10.4.19 Argentina Revenue Forecast (2024-2029)
    • 10.4.20 Colombia Revenue Forecast (2024-2029)
    • 10.4.21 Turkey Revenue Forecast (2024-2029)
    • 10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
    • 10.4.23 South Africa Revenue Forecast (2024-2029)
    • 10.4.24 Egypt Revenue Forecast (2024-2029)

11 Industry Chain Analysis of Powder-based, Needle-free Injection System

  • 11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Powder-based, Needle-free Injection System
    • 11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Powder-based, Needle-free Injection System
    • 11.1.2 Major Equipment Suppliers with Contact Information Analysis of Powder-based, Needle-free Injection System
  • 11.2 Downstream Major Consumers Analysis of Powder-based, Needle-free Injection System
  • 11.3 Major Suppliers of Powder-based, Needle-free Injection System with Contact Information
  • 11.4 Supply Chain Relationship Analysis of Powder-based, Needle-free Injection System

12 Powder-based, Needle-free Injection System New Project Investment Feasibility Analysis

  • 12.1 Powder-based, Needle-free Injection System New Project SWOT Analysis
  • 12.2 Powder-based, Needle-free Injection System New Project Investment Feasibility Analysis
    • 12.2.1 Project Name
    • 12.2.2 Investment Budget
    • 12.2.3 Project Product Solutions
    • 12.2.4 Project Schedule

13 Powder-based, Needle-free Injection System Research Findings and Conclusion

    14 Appendix

    • 14.1 Research Methodology
    • 14.2 References and Data Sources
      • 14.2.1 Primary Sources
      • 14.2.2 Secondary Paid Sources
      • 14.2.3 Secondary Public Sources
    • 14.3 Abbreviations and Units of Measurement
    • 14.4 Author Details

    Summary:
    Get latest Market Research Reports on Powder-based, Needle-free Injection System. Industry analysis & Market Report on Powder-based, Needle-free Injection System is a syndicated market report, published as Global Powder-based, Needle-free Injection System Market Report 2018-2029. It is complete Research Study and Industry Analysis of Powder-based, Needle-free Injection System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,200.00
    $5,800.00
    2,569.60
    4,657.40
    3,001.60
    5,440.40
    494,176.00
    895,694.00
    267,648.00
    485,112.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report